CMYA5** |
Cardiomyopathy-associated 5 |
Desmin binding, Vesicular transport |
Cardiomyopathy, schizophrenia |
STAT3** |
Signal transducer and activator of transcription 3 |
Signal transduction, Gene transcription |
Angiogenesis, Vascular leakage |
ADH5** |
alcohol dehydrogenase 5 |
Opposes NO signaling, protein denitrosylation |
Impaired cardiovascular function |
NLRC4 |
NLR family CARD domain containing 4 |
Innate immunity inflammosome |
Inflammatory disease, infantile enterocolitis |
RPL36A*** |
Ribosomal protein L36 |
60S ribosomal subunit Translational regulation |
Hepatocellular carcinoma |
RPLP2*** |
ribosomal protein lateral stalk subunit P2 |
Phosphoprotein involved in protein elongation |
Upregulated in many cancers |
SLC16A4* |
Solute carrier family 16 member 4 |
Monocarboxylate transporter for pH and energy homeostasis |
Prognostic biomarker in ccRCC |
TNFSF8 |
tumor necrosis factor superfamily member 8 |
CD30 ligand |
Inflammation |
ZNF16 |
zinc finger protein 16 |
Transcription factor |
Erythroid and megakaryocyte differentiation |
IFNA13** |
interferon alpha 13 |
Inflammatory/reproductive cytokine |
Downregulated in dilated cardiomyopathy |
SGCB** |
Sarcoglycan beta |
Dystrophin complex, sarcoglycan transport |
Limb-girdle muscular dystrophy cardiomyopathy |
KCNJ12** |
potassium voltage-gated channel subfamily J member 12 |
Repolarization of cardiac muscle |
Dilated cardiomyopathy |
MED10** |
mediator complex subunit 10 |
RNA Pol-II transcriptional regulation |
Heart valve development |
GOSR2** |
golgi SNAP receptor complex member 2 |
Vesicular trafficking |
Familial essential hypertension |
*Prognostic renal cancer biomarker
|
**Association with vascular or heart biology
|
***Cancer association
|